PTPN22 and neoplasm: In vivo using MDA-MB-435 tumor-bearing mice, the lymphatic vessel density of popliteal LNs was remarkably lower after the LyP-1-liposomes-DOX treatment when compared to the liposomes-DOX, suggesting the excellent treatment of destruction of tumor-associated lymphatic vessels.